Page last updated: 2024-08-17

levodopa and ropinirole

levodopa has been researched along with ropinirole in 155 studies

Research

Studies (155)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (0.65)	18.7374
1990's	15 (9.68)	18.2507
2000's	85 (54.84)	29.6817
2010's	49 (31.61)	24.3611
2020's	5 (3.23)	2.80

Authors

Authors	Studies
Bottomley, JM; Kleedorfer, B; Lees, AJ; Sree-Haran, N; Stern, GM	1
Agid, Y; Belal, S; Bonnet, AM; Dubois, B; Marle, C; Vidailhet, MJ	1
Bottomley, JM; Frankel, JP; Haran, NS; Kapoon, R; Lees, AJ; Pirtosek, Z; Stern, GM	1
Brefel, C; Fuell, D; Lees, AJ; Montastruc, JL; Pirtosek, Z; Rascol, O; Senard, JM	1
Fuell, D; Lees, AJ; Montastruc, JL; Pirtosek, Z; Rascol, O; Senard, JM	1
Brooks, DJ; Burn, DJ; Torjanski, N	1
Barbato, L; Marsden, CD; Monge, A; Nordera, G; Ruggieri, S; Stocchi, F; Vacca, L	1
Brooks, DJ; Brunt, ER; Korczyn, AD; Poewe, WH; Rascol, O; Stocchi, F	1
Banerji, T; Jenner, P; Marsden, CD; Pearce, RK	1
Fernandez, HH; Friedman, JH	1
Fahn, S; Hurtig, H; Lieberman, A; Olanow, CW; Sethi, K; Swanson, P; Waters, CH; Yahr, M	1
Beerahee, A; Burns, E; Citerone, DR; Cyronak, MJ; Fitzpatrick, KL; Leigh, TJ; Lennox, G; Lopez-Gil, A; Taylor, AC; Vakil, SD	1
Brunt, ER; Korczyn, AD; Larsen, JP; Nagy, Z; Poewe, WH; Ruggieri, S	1
Phillips, P	1
Weiner, WJ	1
Montastruc, JL; Rascol, O; Senard, JM	1
LeWitt, PA	1
Brooks, DJ; Clarke, CE; De Deyn, PP; Korczyn, AD; Lang, AE; Rascol, O	1
Dawson, TM; Marsh, L	1
Clarke, CE; Deane, KH	2
Cassel, W; Krüger, HP; Möller, JC; Oertel, WH; Peter, JH; Stiasny, K	1
Earnhart, M; Hiner, BC	1
Yamamoto, T	1
Frucht, S	1
Factor, SA; Weiner, WJ	1
Fukuzaki, K; Kamenosono, T; Kitazumi, K; Nagata, R	1
Lachenmayer, L; Reichmann, H	1
Sternon, J; Supiot, F; Zegers de Beyl, D	1
Masson, C	1
Ingvarsson, PE; Johnels, B; Olsson, T; Steg, G	1
Baillet, C; Callizot, N; Guénet, JL; Poindron, P; Warter, JM	1
Jackson, MJ; Jenner, P; Maratos, EC; Pearce, RK	1
Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, S; Moramarco, A; Palagano, G; Zenzola, A	1
Bamias, C; Hardy, P; Pocock, S; Warner, J; White, IR	1
Etminan, M; Rochon, PA; Samii, A; Takkouche, B	1
Müngersdorf, M; Reichmann, H; Sommer, M; Sommer, U	1
Mazzoni, P	1
Morrish, P	1
Brooks, DJ; Brunt, ER; Korczyn, AD; Montastruc, JL; Stocchi, F	1
Keens, J; Schrag, A; Warner, J	1
Montgomery, EB	2
Cannizzaro, C; Jenner, P; Pearce, RK; Rose, S; Tel, BC; Zeng, BY	1
Jennings, D; Marek, K; Seibyl, J	1
Hirsch, EC; Muriel, MP; Orieux, G	1
Clarke, CE; Guttman, M	1
Bailey, DL; Brooks, DJ; Ito, K; Morrish, PK; Pavese, N; Rakshi, JS; Uema, T	1
Einarson, TR; Iskedjian, M	1
Reichmann, H	1
Cho, IS; Ha, JH; Im, JH; Lee, MC	1
Quinn, NP	1
Berardelli, A; De Pandis, MF; Modugno, N; Ruggieri, S; Stocchi, F; Thomas, A; Vacca, L; Valente, M	1
Beier, KM; Berger, Ch; Mehrhoff, FW; Meinck, HM	1
MacMahon, DG	1
Morrish, PK	1
Brooks, DJ; Davis, M; Hauser, RA; Lang, AE; Nahmias, C; Poewe, WH; Rascol, O; Remy, P; Reske, S; Ribeiro, MJ; Stoessl, AJ; Watts, RL; Whone, AL	1
Inzelberg, R; Nisipeanu, P; Schechtman, E	1
Jähnel, M	1
Bezard, E; Brotchie, JM; Crossman, AR; Grimée, R; Hill, MP; Klitgaard, H; McGuire, SG; Michel, A	1
Brotchie, JM; Chalon, S; Crossman, AR; Ravenscroft, P	1
Jankovic, J; Le, W; Pan, T	1
Brocco, M; Brotchie, J; Crossman, A; Di Cara, B; Gobert, A; Hill, M; Jackson, M; Jenner, P; Joyce, JN; McGuire, S; Millan, MJ; Peglion, JL; Smith, L	1
Brotchie, JM; Crossman, AR; Millan, MJ; Nicholson, SL; Ravenscroft, P; Silverdale, MA	1
Morgan, JC; Sethi, KD	1
Bailey, DL; Brooks, DJ; Pavese, N; Remy, P; Whone, AL	1
Grosset, D; Grosset, K; Macphee, G; Needleman, F	1
Cassel, W; Haja, D; Körner, Y; Krüger, HP; Meindorfner, C; Möller, JC; Oertel, WH; Stiasny-Kolster, K	1
Bara-Jimenez, W; Chase, TN; Dimitrova, T; Favit, A; Mouradian, MM; Sherzai, A	1
Jost, WH	1
Kurlan, R	1
Althoff, R; Jacobson, J; Martineau, RJ; Singh, A	1
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C	1
Kakar, RS; Kushida, CA	1
Hauser, RA; Lyons, KE; Pahwa, R	1
Carta, M; Cenci, MA; Fisone, G; Håkansson, K; Lundblad, M; Usiello, A	1
Angersbach, D; Buchwald, B; Reichmann, H	1
Ahlskog, JE; Bower, JH; Josephs, KA; Klos, KJ; Matsumoto, JY	1
Schapira, AH	1
Cercy, SP; Walker, RH; Warwick, R	1
Deleu, D; Hanssens, Y	1
Abdalla, M; Brooks, DJ; Clarke, CE; De Deyn, PP; Korczyn, AD; Lang, AE; Rascol, O	1
Bi, LL; Chen, XY; Jia, YY; Luo, XX; Wen, AD; Zhong, DF	1
Al-Barghouthy, G; Jackson, MJ; Jenner, P; Rose, S; Smith, LA	1
Barone, P; Clarke, Z; Ellis, A; Lamb, J	1
Angersbach, D; Buchwald, B; Jost, WH	1
Abe, T; Hasegawa, K; Kanazawa, I; Kondo, T; Kuno, S; Mizuno, Y; Nakashima, M; Yamamoto, M	1
De Deyn, PP; Hauser, RA; Jon Stoessl, A; Korczyn, AD; Lang, AE; Poewe, W; Rascol, O; Watts, RL	1
Allen, RP; Hening, W; Tenzer, P; Winkelman, JW	1
Jackson, MJ; Jenner, P; Olanow, W; Rose, S; Smith, LA; Stockwell, KA; Tayarani-Binazir, K; Zubair, M	1
Brooks, D; Rascol, O; Ross, IN; Sharma, JC	1
Molokwu, OC	1
Ball, E; Caivano, CK	1
Bares, M; Krajcovicová, L; Rektor, I; Rektorová, I	1
Bassetti, CL; Siccoli, MM; Valko, PO	1
Ferini-Strambi, L	1
Ahlskog, JE; Bostwick, JM; Bower, JH; Hecksel, KA; Stevens, SR	1
Grimm, C; Kirch, W; Köberlein, J; Nelles, S; Pittrow, D; Rychlik, R	1
Cho, JY; Cho, YJ; Hong, KS; Jeon, BS; Kim, HJ; Lee, DH; Park, SY; Seo, SY	1
Asmus, F; Berg, D; Reimold, M; Schöls, L; Synofzik, M	1
Kulisevsky, J; Pagonabarraga, J	2
Bergmann, L; Jost, WH	1
Dunnett, SB; Lane, EL	1
Koester, J; Lang, AE; Potenza, MN; Siderowf, AD; Stacy, M; Voon, V; Weintraub, D; Whetteckey, J; Wunderlich, GR	1
Adams, B; Earl, NL; Gray, AM; Hauser, RA; Lyons, KE; Olanow, W; Pahwa, R; Sethi, K; Stern, M; Watts, RL	1
Kapsoritakis, AN; Kardasi, M; Manolakis, AC; Potamianos, SP; Psychos, AK; Tsiopoulos, FD	1
Bozi, M; Christodoulou, C; Douzenis, A; Gasparinatos, G; Stamboulis, E; Stefanis, C; Stefanis, L; Stefanis, N	1
Giorgi, L; Hunter, B; Schapira, AH; Stocchi, F	1
Allen, RP; Ball, E; Calloway, MO; Higbie, RL; Lee, MR; Manjunath, R; Nisbet, PA; Ondo, WG	1
Buttarelli, FR; Campanelli, D; Fanciulli, A; Misasi, R; Pontieri, FR	1
Benko, R; Jain, L; Safranek, S	1
Budrewicz, S; Jaskólska, A; Jaskólski, A; Koszewicz, M; Marusiak, J	1
Hasegawa, K; Hattori, N; Sakamoto, T	1
Björklund, A; Carta, M; Garcia, J; Shin, E; Winkler, C	1
George, S; Jones, HB	1
de Biase, S; Gigli, GL; Lorenzut, S; Merlino, G; Valente, M	1
Aurora, RN; Bista, SR; Casey, KR; Kristo, DA; Lamm, CI; Rosenberg, RS; Rowley, JA; Tracy, SL; Zak, RS	1
Daghem, M; Grosset, DG; Grosset, KA; Macphee, GJ; Newman, EJ; Nissen, T; Odin, P; Pal, G; Stewart, M	1
Dostal, M; Schaefer, C; Sobesky, J; Weber-Schoendorfer, C	1
Altenmüller, E; Bardinet, E; Hälbig, TD; Schüpbach, M; van Vugt, FT; Yelnik, J	1
Arai, M	1
Sheehan, J; Thorpe, M; Wilson, L	1
Agúndez, JA; Alonso-Navarro, H; García-Martín, E; Jiménez-Jiménez, FJ	1
Cai, M; Cao, H; Chen, S; Cheng, Y; Li, J; Liu, C; Qu, Q; Wang, J; Wang, Z; Zhang, B; Zhang, X; Zhang, Z; Zhu, R	1
Björklund, A; Carta, M; Fidalgo, C; Lisci, C; Shin, E; Stancampiano, R; Tronci, E	1
Snider, S	1
Alonso-Canovas, A; Garcia-Ruiz, PJ; Herranz Barcenas, A; Mahillo Fernandez, I; Martinez Castrillo, JC; Mata, M; Olmedilla Gonzalez, N; Sanchez Alonso, P; Vela, L	1
Bassetti, CL; Ferini-Strambi, L; Fulda, S; Maestri, M; Manconi, M; Marelli, S; Staedler, C; Zucconi, M	1
Merello, M; Rossi, M	1
Hasegawa, K; Hattori, N; Kondo, T; Mizuno, Y; Murata, M; Nomoto, M; Takahashi, M; Takeuchi, M; Tomida, T	1
Chang, MC; Jang, SH; Kwon, YM	1
Jenner, P; Kanda, T; Kawai-Uchida, M; Mori, A; Okita, E; Soshiroda, K; Uchida, S	2
Cai, M; Chen, S; Cheng, Y; Hu, J; Li, J; Liu, C; Qu, Q; Wang, J; Wang, Z; Zhang, B; Zhang, X; Zhang, Z; Zhu, R	1
Bauer, L; Chung, SJ; Ikeda, J; Jeon, BS; Kim, JM; Kim, JW; Singh, P; Thierfelder, S	2
Fernández-Bobadilla, R; Gironell, A; Kulisevsky, J; Martínez-Horta, S; Pagonabarraga, J; Pascual-Sedano, B; Pérez-Pérez, J; Sierra, S	1
Kanaya, Y; Kono, R; Kuriyama, M; Shiga, Y; Shimoe, Y; Takeshima, S	1
Jo, J; Mousa, SA; Sahli, ZT; Tarazi, FI	1
Ahmadouk, NA; Gopaluni, S; Sherif, M	1
Chriscoe, S; Davy, M; Jimenez, T; Upward, J; VanMeter, S; Zesiewicz, TA	1
Ji, F; Jiang, R; Su, Z; Xue, R; Zhou, Y; Zhu, X; Zhuo, C	1
Sinclair, PM	1
Doladé, NG; Figueras, A; García, GC; Lanteri, PF; Leguia, A	1
Baik, JS; Cho, J; Jeon, B; Kim, HT; Kim, JM; Kim, JW; Koh, SB; Kwon, OD; Lee, HW; Lee, JY; Ma, HI; Yoon, WT	1
Cooper, J; Ni, X; Ning, Y; Parks, D; Refoios Camejo, R; Yi, B; Zhao, H	1
Fukuta, H; Hasegawa, K; Hattori, N; Mochizuki, H; Nomoto, M; Okawa, K; Terahara, T; Uchida, E	2
Green, CE; Lane, SD; Moeller, FG; Schmitz, JM; Suchting, R; Vincent, J; Webber, HE	1
Ando, H; Doyu, M; Fujikake, A; Fukuoka, T; Hayashi, M; Ito, C; Izumi, M; Kawagashira, Y; Koide, H; Nakashima, K; Niwa, JI; Ogawa, K; Oiwa, H; Okada, Y; Taguchi, S; Tokui, K; Tsunoda, Y; Yasumoto, A; Yuasa, T	1
Cenci, MA; Elabi, OF; Espa, E; Fanni, S; Skovgård, K	1

Reviews

35 review(s) available for levodopa and ropinirole

Article	Year
Ropinirole in the symptomatic treatment of Parkinson's disease. Journal of neural transmission. Supplementum, 1995, Volume: 45 Topics: Antiparkinson Agents; Clinical Trials, Phase II as Topic; Dopamine Agonists; Drug Therapy, Combination; Drugs, Investigational; Humans; Indoles; Levodopa; Parkinson Disease	1995
The initial treatment of Parkinson's disease should begin with levodopa. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:5 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Drug Therapy, Combination; Essential Tremor; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine; Thiazoles; Time Factors	1999
Treatment of Parkinson's disease should begin with a dopamine agonist. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:5 Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D2; Thiazoles	1999
New drugs for the treatment of Parkinson's disease. Pharmacotherapy, 2000, Volume: 20, Issue:1 Pt 2 Topics: Antiparkinson Agents; Benzophenones; Benzothiazoles; Cabergoline; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Drug Synergism; Enzyme Inhibitors; Ergolines; Humans; Indoles; Levodopa; Nitrophenols; Parkinson Disease; Pramipexole; Thiazoles; Tolcapone	2000
Ropinirole for levodopa-induced complications in Parkinson's disease. The Cochrane database of systematic reviews, 2000, Issue:3 Topics: Antiparkinson Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dopamine Agonists; Dyskinesias; Humans; Indoles; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic	2000
Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease. The Cochrane database of systematic reviews, 2000, Issue:3 Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dyskinesias; Humans; Indoles; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic	2000
["Sleep attacks" in Parkinson patients. A side effect of nonergoline dopamine agonists or a class effect of dopamine agonists?]. Der Nervenarzt, 2000, Volume: 71, Issue:8 Topics: Accidents, Traffic; Automobile Driving; Benzothiazoles; Contraindications; Dopamine Agents; Dopamine Agonists; Germany; Humans; Indoles; Legislation, Drug; Levodopa; Narcolepsy; Parkinson Disease; Pramipexole; Thiazoles	2000
[Parkinson disease: diagnostic and therapeutic criteria]. Presse medicale (Paris, France : 1983), 2001, Mar-03, Volume: 30, Issue:8 Topics: Activities of Daily Living; Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Globus Pallidus; Humans; Indoles; Levodopa; Lewy Body Disease; Lisuride; Male; Mental Status Schedule; Neurosurgery; Parkinson Disease; Parkinsonian Disorders; Piribedil; Psychiatric Status Rating Scales; Serotonin Receptor Agonists; Stereotaxic Techniques; Supranuclear Palsy, Progressive; Surveys and Questionnaires; Thalamus	2001
Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials. Drug safety, 2001, Volume: 24, Issue:11 Topics: Antiparkinson Agents; Benzothiazoles; Disorders of Excessive Somnolence; Dopamine Agonists; Drug Therapy, Combination; Humans; Indoles; Levodopa; MEDLINE; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Risk Factors; Thiazoles	2001
Two advances in the management of Parkinson disease. Cleveland Clinic journal of medicine, 2002, Volume: 69, Issue:8 Topics: Age Factors; Antiparkinson Agents; Benzothiazoles; Carbidopa; Dyskinesias; Electric Stimulation Therapy; Forecasting; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Risk Factors; Stereotaxic Techniques; Thiazoles	2002
Do dopamine agonists or levodopa modify Parkinson's disease progression? European journal of neurology, 2002, Volume: 9 Suppl 3 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Carrier Proteins; Dihydroxyphenylalanine; Disease Progression; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Humans; Indoles; Iodine Radioisotopes; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Radiopharmaceuticals; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tropanes	2002
Dopamine agonist monotherapy in Parkinson's disease. Lancet (London, England), 2002, Nov-30, Volume: 360, Issue:9347 Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Ergolines; Humans; Indoles; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	2002
Neuroprotection in idiopathic Parkinson's disease. Journal of neurology, 2002, Volume: 249 Suppl 3 Topics: Antiparkinson Agents; Benzothiazoles; Cell Death; Dopamine Agonists; Humans; Indoles; Levodopa; Neuroprotective Agents; Parkinson Disease; Pramipexole; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	2002
Cabergoline, pramipexole and ropinirole used as monotherapy in early Parkinson's disease: an evidence-based comparison. Drugs & aging, 2003, Volume: 20, Issue:11 Topics: Age of Onset; Benzothiazoles; Cabergoline; Dopamine Agonists; Double-Blind Method; Ergolines; Evidence-Based Medicine; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Thiazoles	2003
Ropinirole: current status of the studies. Journal of neurology, 2004, Volume: 251 Suppl 6 Topics: Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Indoles; Levodopa; Neuroprotective Agents; Parkinson Disease	2004
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5 Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone	2005
Ropinirole in the treatment of restless legs syndrome. Expert review of neurotherapeutics, 2005, Volume: 5, Issue:1 Topics: Dopamine Agonists; Enzyme Inhibitors; Expert Testimony; Humans; Indoles; Levodopa; Restless Legs Syndrome	2005
Ropinirole therapy for Parkinson's disease. Expert review of neurotherapeutics, 2004, Volume: 4, Issue:4 Topics: Antiparkinson Agents; Dopamine Agonists; Drug Therapy, Combination; Humans; Indoles; Levodopa; Parkinson Disease	2004
Present and future drug treatment for Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 2005, Volume: 76, Issue:11 Topics: Benzothiazoles; Corpus Striatum; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Humans; Indans; Indoles; Levodopa; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Pramipexole; Psychomotor Performance; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Substantia Nigra; Thiazoles; Urinary Incontinence	2005
Restless legs syndrome: nonpharmacologic and pharmacologic treatments. Geriatrics, 2007, Volume: 62, Issue:10 Topics: Amines; Anemia, Iron-Deficiency; Anticonvulsants; Benzothiazoles; Clonazepam; Cyclohexanecarboxylic Acids; Dopamine Agents; Dopamine Agonists; Ferritins; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Iron; Levodopa; Pramipexole; Restless Legs Syndrome; Trace Elements	2007
Internal medicine: guidance to the diagnosis and management of restless legs syndrome. Southern medical journal, 2008, Volume: 101, Issue:6 Topics: Benzothiazoles; Critical Pathways; Cross-Sectional Studies; Dopamine Agonists; Humans; Indoles; Internal Medicine; Levodopa; Polysomnography; Pramipexole; Primary Health Care; Restless Legs Syndrome; Risk Factors; Treatment Outcome	2008
Treatment options for restless legs syndrome. Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:4 Topics: Benzothiazoles; Dopamine Agonists; Humans; Indoles; Levodopa; Pramipexole; Restless Legs Syndrome	2009
Tolerability and safety of ropinirole versus other dopamine agonists and levodopa in the treatment of Parkinson's disease: meta-analysis of randomized controlled trials. Drug safety, 2010, Feb-01, Volume: 33, Issue:2 Topics: Antiparkinson Agents; Dopamine Agonists; Drug Therapy, Combination; Humans; Indoles; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic	2010
[Clinical data of the prolonged-release formulation of ropinirole]. Fortschritte der Neurologie-Psychiatrie, 2010, Volume: 78 Suppl 1 Topics: Antiparkinson Agents; Benzothiazoles; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Quality of Life	2010
Clinical inquiry. Which drugs work best for early Parkinson's disease? The Journal of family practice, 2012, Volume: 61, Issue:2 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Family Practice; Humans; Indoles; Levodopa; Motor Skills; Neurologic Examination; Parkinson Disease	2012
ADMET considerations for restless leg syndrome drug treatments. Expert opinion on drug metabolism & toxicology, 2012, Volume: 8, Issue:10 Topics: Amines; Anticonvulsants; Benzothiazoles; Carbamates; Cyclohexanecarboxylic Acids; Dopamine Agents; Dopamine Agonists; Ergolines; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Levodopa; Neuralgia; Pramipexole; Pregabalin; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome	2012
The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep, 2012, Aug-01, Volume: 35, Issue:8 Topics: Academies and Institutes; Benzothiazoles; Cabergoline; Carbamates; Dopamine Agents; Ergolines; Evidence-Based Medicine; gamma-Aminobutyric Acid; Humans; Indoles; Levodopa; Nocturnal Myoclonus Syndrome; Pergolide; Peripheral Nervous System Diseases; Pramipexole; Restless Legs Syndrome; Sleep Medicine Specialty; United States; Venous Insufficiency	2012
Anti-Parkinson's disease drugs and pharmacogenetic considerations. Expert opinion on drug metabolism & toxicology, 2013, Volume: 9, Issue:7 Topics: Aryl Hydrocarbon Hydroxylases; Benzothiazoles; Benztropine; Bromocriptine; Cabergoline; Catechols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Ergolines; Genetic Markers; Humans; Indans; Indoles; Levodopa; Lisuride; Nitriles; Parkinson Disease; Pergolide; Pharmacogenetics; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Selegiline	2013
The impact of restless legs syndrome: a familial case study. The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 2013, Volume: 45, Issue:6 Topics: Adult; Analgesics, Opioid; Anticonvulsants; Benzodiazepines; Benzothiazoles; Carbidopa; Dopamine Agonists; Drug Combinations; Family Health; Humans; Incidence; Indoles; Levodopa; Male; Middle Aged; Pramipexole; Prevalence; Restless Legs Syndrome	2013
[Dopaminergic treatment in Parkinson's disease: what has each therapeutic family got to offer?]. Revista de neurologia, 2014, Jan-01, Volume: 58, Issue:1 Topics: Amantadine; Antiparkinson Agents; Cardiovascular Diseases; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Clinical Trials as Topic; Dopamine Agonists; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Food-Drug Interactions; Humans; Indans; Indoles; Levodopa; Mental Disorders; Monoamine Oxidase Inhibitors; Multicenter Studies as Topic; Parkinson Disease; Serotonin Syndrome; Treatment Outcome	2014
Clinical management of restless legs syndrome in end-stage renal disease patients. CNS spectrums, 2017, Volume: 22, Issue:1 Topics: Amines; Analgesics, Opioid; Benzodiazepines; Benzothiazoles; Comorbidity; Cyclohexanecarboxylic Acids; Dopamine Agonists; Excitatory Amino Acid Antagonists; Exercise Therapy; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Intermittent Pneumatic Compression Devices; Kidney Failure, Chronic; Levodopa; Massage; Pramipexole; Quality of Life; Renal Dialysis; Restless Legs Syndrome; Sleep Hygiene; Tetrahydronaphthalenes; Thiophenes	2017
Interventions for chronic kidney disease-associated restless legs syndrome. The Cochrane database of systematic reviews, 2016, 11-07, Volume: 11 Topics: Amines; Anticonvulsants; Ascorbic Acid; Cyclohexanecarboxylic Acids; Dopamine Agonists; Exercise Therapy; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Iron-Dextran Complex; Levodopa; Quality of Life; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Renal Replacement Therapy; Resistance Training; Restless Legs Syndrome; Vitamin E; Vitamins	2016
Comparison for Efficacy and Tolerability among Ten Drugs for Treatment of Parkinson's Disease: A Network Meta-Analysis. Scientific reports, 2017, 04-04, Volume: 8 Topics: Bromocriptine; Cluster Analysis; Dopamine Agonists; Drug Therapy, Combination; Humans; Indoles; Levodopa; Network Meta-Analysis; Parkinson Disease; Picolinic Acids; Pramipexole; Selegiline; Tetrahydronaphthalenes; Thiophenes	2017
Interventions for chronic kidney disease-associated restless legs syndrome. International journal of evidence-based healthcare, 2018, Volume: 16, Issue:3 Topics: Exercise Therapy; Gabapentin; Humans; Indoles; Iron-Dextran Complex; Levodopa; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Restless Legs Syndrome; Vitamins	2018
Indirect Comparison of Ropinirole and Pramipexole as Levodopa Adjunctive Therapy in Advanced Parkinson's Disease: A Systematic Review and Network Meta-Analysis. Advances in therapy, 2019, Volume: 36, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Combined Modality Therapy; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole	2019

Trials

42 trial(s) available for levodopa and ropinirole

Article	Year
Treatment of Parkinson's disease with novel dopamine D2 agonist SK&F 101468. Lancet (London, England), 1989, Jun-24, Volume: 1, Issue:8652 Topics: Dopamine Agents; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pilot Projects	1989
A placebo-controlled study of ropinirole, a new D2 agonist, in the treatment of motor fluctuations of L-DOPA-treated parkinsonian patients. Advances in neurology, 1996, Volume: 69 Topics: Antiparkinson Agents; Dopamine Agonists; Drug Therapy, Combination; Humans; Indoles; Levodopa; Movement Disorders; Parkinson Disease; Receptors, Dopamine D2	1996
Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease. Clinical neuropharmacology, 1996, Volume: 19, Issue:3 Topics: Adult; Aged; Antiparkinson Agents; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease	1996
Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group. Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13, Issue:1 Topics: Adult; Aged; Analysis of Variance; Antiparkinson Agents; Confidence Intervals; Disease Progression; Dopamine Agonists; Double-Blind Method; Female; Humans; Indoles; Levodopa; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Parkinson Disease; Regression Analysis; Severity of Illness Index; Treatment Outcome	1998
A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease. Ropinirole Study Group. Neurology, 1998, Volume: 51, Issue:4 Topics: Antiparkinson Agents; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Female; Humans; Indoles; Levodopa; Male; Parkinson Disease; Prospective Studies	1998
Lack of a pharmacokinetic interaction at steady state between ropinirole and L-dopa in patients with Parkinson's disease. Pharmacotherapy, 1999, Volume: 19, Issue:2 Topics: Aged; Antiparkinson Agents; Area Under Curve; Carbidopa; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease	1999
A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson's disease. The 053 Study Group. Neurology, 1999, Jul-22, Volume: 53, Issue:2 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Bromocriptine; Double-Blind Method; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors	1999
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. The New England journal of medicine, 2000, May-18, Volume: 342, Issue:20 Topics: Aged; Antiparkinson Agents; Disease-Free Survival; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Incidence; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Risk Factors	2000
[1st long-term double-blind study of effectiveness and dyskinesia prevention of ropinirol]. Der Nervenarzt, 2000, Volume: 71, Issue:12 Topics: Adult; Aged; Dopamine Agonists; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Prospective Studies; Treatment Outcome	2000
The Posturo-Locomotion-Manual Test. A simple method for the characterization of neurological movement disturbances. Advances in neurology, 2001, Volume: 87 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Apomorphine; Diagnosis, Differential; Diagnostic Techniques, Neurological; Humans; Indoles; Levodopa; Locomotion; Middle Aged; Parkinson Disease; Posture	2001
High-dose therapy with ropinirole in patients with Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2001, Volume: 108, Issue:11 Topics: Aged; Antiparkinson Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesias; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Prospective Studies	2001
A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa. Journal of neural transmission (Vienna, Austria : 1996), 2002, Volume: 109, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Bromocriptine; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Indoles; Levodopa; Logistic Models; Male; Middle Aged; Odds Ratio; Parkinson Disease	2002
Ropinirole for the treatment of tremor in early Parkinson's disease. European journal of neurology, 2002, Volume: 9, Issue:3 Topics: Aged; Antiparkinson Agents; Bromocriptine; Double-Blind Method; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome; Tremor	2002
A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: an 18F-dopa PET study. Journal of neural transmission (Vienna, Austria : 1996), 2002, Volume: 109, Issue:12 Topics: Aged; Antiparkinson Agents; Dihydroxyphenylalanine; Disease Progression; Fluorine Radioisotopes; Follow-Up Studies; Humans; Indoles; Levodopa; Middle Aged; Parkinson Disease; Tomography, Emission-Computed	2002
Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study. Journal of neurology, 2003, Volume: 250, Issue:1 Topics: Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Treatment Outcome	2003
Combination of two different dopamine agonists in the management of Parkinson's disease. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2002, Volume: 23 Suppl 2 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Prospective Studies; Thiazoles; Treatment Outcome	2002
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study. Annals of neurology, 2003, Volume: 54, Issue:1 Topics: Adult; Aged; Brain; Caudate Nucleus; Corpus Striatum; Disease Progression; Dopamine; Dopamine Agonists; Double-Blind Method; Female; Fluorine Radioisotopes; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Putamen; Receptors, Dopamine D2; Severity of Illness Index; Substantia Nigra; Tomography, Emission-Computed	2003
Cabergoline, pramipexole and ropinirole used as monotherapy in early Parkinson's disease: an evidence-based comparison. Drugs & aging, 2003, Volume: 20, Issue:11 Topics: Age of Onset; Benzothiazoles; Cabergoline; Dopamine Agonists; Double-Blind Method; Ergolines; Evidence-Based Medicine; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Thiazoles	2003
Ropinirole versus levodopa in Parkinson's disease. Current neurology and neuroscience reports, 2004, Volume: 4, Issue:4 Topics: Adult; Aged; Double-Blind Method; Humans; Indoles; Internationality; Levodopa; Middle Aged; Parkinson Disease; Prospective Studies; Tomography, Emission-Computed	2004
A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:7 Topics: Algorithms; Antiparkinson Agents; Canada; Dihydroxyphenylalanine; Dopamine Agents; France; Germany; Humans; Image Interpretation, Computer-Assisted; Indoles; Levodopa; Parkinson Disease; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome; United Kingdom	2004
Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:10 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Carbidopa; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Indoles; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Pilot Projects; Pramipexole; Thiazoles	2004
[Practical experience on improving activities of daily living competence in Parkinson's patients treated with ropinirole. Results of a applied study]. Der Nervenarzt, 2005, Volume: 76, Issue:10 Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Dose-Response Relationship, Drug; Drug Combinations; Female; Germany; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Product Surveillance, Postmarketing; Treatment Outcome	2005
Development of dyskinesias in a 5-year trial of ropinirole and L-dopa. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:11 Topics: Antiparkinson Agents; Confidence Intervals; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Indoles; Levodopa; Longitudinal Studies; Parkinson Disease; Predictive Value of Tests; Proportional Hazards Models; Risk Factors; Survival Analysis	2006
The effect of Madopar on the pharmacokinetics of ropinirole in healthy Chinese volunteers. Journal of pharmaceutical and biomedical analysis, 2007, Jan-17, Volume: 43, Issue:2 Topics: Adult; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Asian People; Benserazide; Chromatography, High Pressure Liquid; Cross-Over Studies; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Female; Humans; Indoles; Levodopa; Linear Models; Male; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry	2007
Sumanirole versus placebo or ropinirole for the adjunctive treatment of patients with advanced Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2007, Mar-15, Volume: 22, Issue:4 Topics: Adult; Benzimidazoles; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indoles; Levodopa; Male; Parkinson Disease; Severity of Illness Index; Treatment Outcome	2007
Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study. Movement disorders : official journal of the Movement Disorder Society, 2007, Oct-15, Volume: 22, Issue:13 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Case-Control Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Mobility Limitation; Neurologic Examination; Parkinson Disease; Treatment Outcome	2007
Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa. Movement disorders : official journal of the Movement Disorder Society, 2007, Volume: 22, Issue:16 Topics: Aged; Amantadine; Antiparkinson Agents; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome	2007
Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2010, May-15, Volume: 25, Issue:7 Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Delayed-Action Preparations; Disability Evaluation; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Quality of Life; Surveys and Questionnaires	2010
PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2011, Volume: 26, Issue:7 Topics: Aged; Antiparkinson Agents; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Treatment Outcome	2011
Dopaminergic drug-induced modulation of the expression of the dopamine transporter in peripheral blood lymphocytes in Parkinson's disease. Pharmacological reports : PR, 2011, Volume: 63, Issue:4 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Carbidopa; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Drug Combinations; Female; Flow Cytometry; Gene Expression Regulation; Humans; Indoles; Levodopa; Lymphocytes; Male; Middle Aged; Parkinson Disease; Pramipexole	2011
Pharmacokinetics and effect of food after oral administration of prolonged-release tablets of ropinirole hydrochloride in Japanese patients with Parkinson's disease. Journal of clinical pharmacy and therapeutics, 2012, Volume: 37, Issue:5 Topics: Administration, Oral; Aged; Asian People; Delayed-Action Preparations; Dopamine Agonists; Female; Follow-Up Studies; Food-Drug Interactions; Humans; Indoles; Levodopa; Male; Parkinson Disease; Tablets	2012
Ropinirole does not affect plasma arginine vasopressin levels in patients with advanced Parkinson's disease. Neuro endocrinology letters, 2012, Volume: 33, Issue:7 Topics: Aged; Arginine Vasopressin; Carbidopa; Catechols; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Humans; Inappropriate ADH Syndrome; Indoles; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease	2012
The efficacy and safety of ropinirole prolonged release tablets as adjunctive therapy in Chinese subjects with advanced Parkinson's disease: a multicenter, double-blind, randomized, placebo-controlled study. Parkinsonism & related disorders, 2013, Volume: 19, Issue:11 Topics: Aged; Antiparkinson Agents; Asian People; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Tablets, Enteric-Coated; Treatment Outcome	2013
Polysomnographic record and successful management of augmentation in restless legs syndrome/Willis-Ekbom disease. Sleep medicine, 2014, Volume: 15, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Benzothiazoles; Delayed-Action Preparations; Dopamine Agonists; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Polysomnography; Pramipexole; Restless Legs Syndrome; Sleep Stages; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome	2014
Rotigotine vs ropinirole in advanced stage Parkinson's disease: a double-blind study. Parkinsonism & related disorders, 2014, Volume: 20, Issue:12 Topics: Adult; Aged; Analysis of Variance; Antiparkinson Agents; Double-Blind Method; Female; Humans; Indoles; Japan; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome	2014
An open-label extension study to evaluate the safety of ropinirole prolonged release in Chinese patients with advanced Parkinson's disease. Current medical research and opinion, 2015, Volume: 31, Issue:4 Topics: Adolescent; Adult; Aged; Antiparkinson Agents; Asian People; Delayed-Action Preparations; Drug Liberation; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Young Adult	2015
Switch from oral pramipexole or ropinirole to rotigotine transdermal system in advanced Parkinson's disease: an open-label study. Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:7 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Drug Substitution; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Tetrahydronaphthalenes; Thiophenes	2015
Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson's disease: an open-label study. BMC neurology, 2015, Feb-28, Volume: 15 Topics: Activities of Daily Living; Administration, Cutaneous; Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Sleep Wake Disorders; Tetrahydronaphthalenes; Thiophenes	2015
A randomized, fixed-dose, dose-response study of ropinirole prolonged release in advanced Parkinson's disease. Neurodegenerative disease management, 2017, Volume: 7, Issue:1 Topics: Adult; Antiparkinson Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Levodopa; Maintenance Chemotherapy; Male; Parkinson Disease	2017
Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial. Journal of neurology, neurosurgery, and psychiatry, 2019, Volume: 90, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug Combinations; Drug Substitution; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole	2019
Ropinirole Patch Versus Placebo, Ropinirole Extended-Release Tablet in Advanced Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society, 2020, Volume: 35, Issue:9 Topics: Antiparkinson Agents; Double-Blind Method; Humans; Indoles; Levodopa; Parkinson Disease; Tablets	2020
The effects of combination levodopa-ropinirole on cognitive improvement and treatment outcome in individuals with cocaine use disorder: A bayesian mediation analysis. Drug and alcohol dependence, 2021, 08-01, Volume: 225 Topics: Adult; Bayes Theorem; Cocaine; Cognition; Double-Blind Method; Humans; Indoles; Levodopa; Mediation Analysis; Treatment Outcome	2021

Other Studies

79 other study(ies) available for levodopa and ropinirole

Article	Year
Ropinirole (SK and F 101468) in the treatment of Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1991, Volume: 54, Issue:10 Topics: Aged; Dopamine Agents; Dose-Response Relationship, Drug; Humans; Indoles; Levodopa; Middle Aged; Neurologic Examination; Parkinson Disease	1991
Ropinirole without levodopa in Parkinson's disease. Lancet (London, England), 1990, Aug-04, Volume: 336, Issue:8710 Topics: Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease	1990
The long-duration action of levodopa may be due to a postsynaptic effect. Clinical neuropharmacology, 1997, Volume: 20, Issue:5 Topics: Adult; Antiparkinson Agents; Dopamine Agents; Dopamine Agonists; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine D2; Substance Withdrawal Syndrome; Time Factors	1997
De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset. Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Bromocriptine; Callithrix; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Indoles; Levodopa; Male; Motor Skills; Neurologic Examination; Parkinson Disease, Secondary; Receptors, Dopamine D2	1998
New anti-parkinsonian drugs. Medicine and health, Rhode Island, 1998, Volume: 81, Issue:7 Topics: Antiparkinson Agents; Benzophenones; Benzothiazoles; Humans; Indoles; Levodopa; Nitrophenols; Parkinson Disease; Pramipexole; Thiazoles; Tolcapone	1998
Several classes of new drugs emerging for Parkinson disease. JAMA, 1999, Sep-08, Volume: 282, Issue:10 Topics: Antiparkinson Agents; Benzothiazoles; Catechol O-Methyltransferase Inhibitors; Catechols; Dopamine Agonists; Enzyme Inhibitors; Humans; Indoles; Levodopa; Nitriles; Parkinson Disease; Pramipexole; Thiazoles	1999
Treatments for Parkinson's disease. Health news (Waltham, Mass.), 2000, Volume: 6, Issue:6 Topics: Antiparkinson Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Indoles; Levodopa; Parkinson Disease	2000
Treatment of early Parkinson's disease. BMJ (Clinical research ed.), 2000, Jul-01, Volume: 321, Issue:7252 Topics: Antiparkinson Agents; Humans; Indoles; Levodopa; Multicenter Studies as Topic; Parkinson Disease; Randomized Controlled Trials as Topic	2000
Ropinirole as compared with levodopa in Parkinson's disease. The New England journal of medicine, 2000, Sep-21, Volume: 343, Issue:12 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Indoles; Levodopa; Parkinson Disease	2000
Ropinirole as compared with levodopa in Parkinson's disease. The New England journal of medicine, 2000, Sep-21, Volume: 343, Issue:12 Topics: Antiparkinson Agents; Dyskinesia, Drug-Induced; Hallucinations; Humans; Indoles; Levodopa; Parkinson Disease	2000
Ropinirole as compared with levodopa in Parkinson's disease. The New England journal of medicine, 2000, Sep-21, Volume: 343, Issue:12 Topics: Antiparkinson Agents; Dyskinesia, Drug-Induced; Humans; Indoles; Levodopa; Parkinson Disease; Sleep	2000
Ropinirole as compared with levodopa in Parkinson's disease. The New England journal of medicine, 2000, Sep-21, Volume: 343, Issue:12 Topics: Antiparkinson Agents; Dyskinesia, Drug-Induced; Humans; Indoles; Levodopa; Parkinson Disease; Quality of Life	2000
Effects of ropinirole on motor behavior in MPTP-treated common marmosets. Pharmacology, biochemistry, and behavior, 2000, Volume: 67, Issue:1 Topics: Animals; Antiparkinson Agents; Bromocriptine; Callithrix; Dopamine Agonists; Female; Indoles; Levodopa; Male; Motor Activity; MPTP Poisoning; Receptors, Dopamine D2; Receptors, Dopamine D3	2000
[Dopaminergic agonists in the treatment of Parkinson's disease]. Revue medicale de Bruxelles, 2000, Volume: 21, Issue:6 Topics: Aged; Antiparkinson Agents; Apomorphine; Benzothiazoles; Biological Availability; Bromocriptine; Catechols; Dopamine Agonists; Drug Combinations; Drug Hypersensitivity; Humans; Hypotension, Orthostatic; Indoles; Levodopa; Metabolic Clearance Rate; Nitriles; Parkinson Disease; Pergolide; Pramipexole; Selegiline; Thiazoles	2000
[Parkinson's disease]. Presse medicale (Paris, France : 1983), 2001, Mar-03, Volume: 30, Issue:8 Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Catechols; Depressive Disorder; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Follow-Up Studies; Humans; Indoles; Levodopa; Lewy Body Disease; Neuroprotective Agents; Nitriles; Parkinson Disease; Parkinsonian Disorders; Pergolide; Psychiatric Status Rating Scales; Psychotic Disorders; Time Factors	2001
The frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome. Neurobiology of disease, 2001, Volume: 8, Issue:3 Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Electromyography; Female; Genes, Recessive; Immunohistochemistry; Indoles; Levodopa; Male; Memory Disorders; Mice; Mice, Inbred C3H; Mice, Neurologic Mutants; Motor Activity; Neurons; Parkinson Disease, Secondary; Postural Balance; Selegiline; Tyrosine 3-Monooxygenase	2001
Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naïve MPTP-lesioned common marmosets (Callithrix jacchus). Movement disorders : official journal of the Movement Disorder Society, 2001, Volume: 16, Issue:4 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Callithrix; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Indoles; Levodopa; Neurologic Examination; Parkinsonian Disorders	2001
Efficacy and tolerability of dopamine agonists in a parkinsonian population. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2001, Volume: 22, Issue:1 Topics: Age of Onset; Aged; Aging; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Ergolines; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome	2001
Randomized clinical trials with added rescue medication: some approaches to their analysis and interpretation. Statistics in medicine, 2001, Oct-30, Volume: 20, Issue:20 Topics: Activities of Daily Living; Antiparkinson Agents; Bromocriptine; Humans; Indoles; Levodopa; Multicenter Studies as Topic; Parkinson Disease; Randomized Controlled Trials as Topic; Regression Analysis; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome	2001
Literature alert. Current neurology and neuroscience reports, 2001, Volume: 1, Issue:4 Topics: Antiparkinson Agents; Dyskinesia, Drug-Induced; Fetal Tissue Transplantation; Humans; Incidence; Indoles; Levodopa; Neurons; Parkinson Disease	2001
Is it time to abandon functional imaging in the study of neuroprotection? Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:2 Topics: Antiparkinson Agents; Brain; Clinical Trials as Topic; Disease Progression; Humans; Indoles; Levodopa; Parkinson Disease; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome	2002
Alterations in striatal neuropeptide mRNA produced by repeated administration of L-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets. Neuroscience, 2002, Volume: 115, Issue:4 Topics: Animals; Antiparkinson Agents; Bromocriptine; Callithrix; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Enkephalins; Female; Indoles; Levodopa; Male; Mazindol; Neostriatum; Neural Pathways; Neuropeptides; Parkinsonian Disorders; Protein Precursors; Receptors, Purinergic P1; RNA, Messenger; Tachykinins	2002
Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:6 Topics: Animals; Antiparkinson Agents; Carbidopa; Corpus Striatum; Cytoplasm; Drug Combinations; Indoles; Levodopa; Male; Microscopy, Immunoelectron; Neurons; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Synaptic Membranes; Tyrosine 3-Monooxygenase	2002
Cost analysis of ropinirole versus levodopa in the treatment of Parkinson's disease. PharmacoEconomics, 2003, Volume: 21, Issue:2 Topics: Adult; Antiparkinson Agents; Benserazide; Canada; Caregivers; Cost Savings; Dopamine Agonists; Drug Costs; Health Care Costs; Humans; Indoles; Levodopa; Middle Aged; Parkinson Disease; Treatment Outcome	2003
Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease A short commentary. Journal of neurology, 2003, Volume: 250, Issue:1 Topics: Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Humans; Indoles; Levodopa; Parkinson Disease	2003
[Sexual delinquency and Parkinson's disease]. Der Nervenarzt, 2003, Volume: 74, Issue:4 Topics: Antiparkinson Agents; Awareness; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Exhibitionism; Expert Testimony; Humans; Impulsive Behavior; Indoles; Levodopa; Libido; Male; Middle Aged; Parkinson Disease; Pedophilia; Sex Offenses	2003
The initial drug treatment of older patients with Parkinson's disease - consider an agonist, but don't demonise dopa. Age and ageing, 2003, Volume: 32, Issue:3 Topics: Antiparkinson Agents; Benzothiazoles; Catechol O-Methyltransferase; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Indoles; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Thiazoles	2003
REAL and CALM: what have we learned? Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:7 Topics: Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Corpus Striatum; Disease Progression; Dopamine; Feasibility Studies; Humans; Indoles; Levodopa; Neurons; Neuroprotective Agents; Parkinson Disease; Pramipexole; Putamen; Reference Values; Sensitivity and Specificity; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	2003
[Pseudopheochromocytoma in Parkinson disease and depression]. Psychiatrische Praxis, 2003, Volume: 30 Suppl 2 Topics: Adrenal Gland Neoplasms; Antidepressive Agents; Antiparkinson Agents; Catecholamines; Depressive Disorder; Diagnosis, Differential; Dopamine Agonists; Drug Therapy, Combination; Female; Flushing; Homovanillic Acid; Humans; Hypertension; Indoles; Levodopa; Middle Aged; Parkinson Disease; Pheochromocytoma; Vanilmandelic Acid	2003
Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:11 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anticonvulsants; Antiparkinson Agents; Callithrix; Dopamine Agents; Drug Synergism; Drug Therapy, Combination; Female; Indoles; Levetiracetam; Levodopa; Male; Parkinsonian Disorders; Piracetam	2003
Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia. Experimental neurology, 2004, Volume: 185, Issue:1 Topics: Animals; Antiparkinson Agents; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Dyskinesia, Drug-Induced; Enkephalins; Gene Expression; In Situ Hybridization; Indoles; Levodopa; Male; Motor Activity; Opioid Peptides; Oxidopamine; Parkinsonian Disorders; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Synaptic Transmission	2004
Slowing Parkinson's disease progression: recent dopamine agonist trials. Neurology, 2004, Jan-27, Volume: 62, Issue:2 Topics: Antiparkinson Agents; Benzothiazoles; Biological Transport; Cell Line, Tumor; Clinical Trials as Topic; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Humans; In Vitro Techniques; Indoles; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuroblastoma; Parkinson Disease; Pramipexole; Thiazoles	2004
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole. The Journal of pharmacology and experimental therapeutics, 2004, Volume: 309, Issue:3 Topics: Acetylcholine; Animals; Callithrix; Cells, Cultured; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Drug Interactions; Dyskinesias; Electrophysiology; Extracellular Space; Humans; Hypokinesia; Indoles; Levodopa; Male; Motor Activity; MPTP Poisoning; Neuroprotective Agents; Oxazines; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Reserpine; Rotation	2004
Selective blockade of D(3) dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate. Experimental neurology, 2004, Volume: 188, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzopyrans; Brain; Callithrix; Disease Models, Animal; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Indoles; Levodopa; Parkinsonian Disorders; Pyrroles; Receptors, Dopamine D2; Receptors, Dopamine D3	2004
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:11 Topics: Adult; Adverse Drug Reaction Reporting Systems; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Feasibility Studies; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Therapeutic Equivalency; Thiazoles	2004
Predictors of sudden onset of sleep in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:11 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Comorbidity; Cross-Sectional Studies; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Narcolepsy; Parkinson Disease; Pramipexole; Risk Factors; Surveys and Questionnaires; Thiazoles	2004
"Levodopa phobia": a new iatrogenic cause of disability in Parkinson disease. Neurology, 2005, Mar-08, Volume: 64, Issue:5 Topics: Aged; Amantadine; Benzothiazoles; Catechols; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Humans; Iatrogenic Disease; Indoles; Levodopa; Male; Middle Aged; Neurology; Neuropharmacology; Neurotoxicity Syndromes; Nitriles; Parkinson Disease; Pramipexole; Selegiline; Thiazoles; Treatment Outcome	2005
Pramipexole, ropinirole, and mania in Parkinson's disease. The American journal of psychiatry, 2005, Volume: 162, Issue:4 Topics: Adult; Antiparkinson Agents; Benzothiazoles; Bipolar Disorder; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Thiazoles	2005
Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia. Experimental neurology, 2005, Volume: 194, Issue:1 Topics: Adenosine A2 Receptor Agonists; Adrenergic Agents; Amantadine; Animals; Antiparkinson Agents; Basal Ganglia; Buspirone; Disease Models, Animal; Disease Progression; Dopamine Agonists; Drug Administration Schedule; Dyskinesia, Drug-Induced; Indoles; Levodopa; Male; Mice; Mice, Inbred C57BL; Oxidopamine; Parkinsonian Disorders; Purines; Receptor, Adenosine A2A; Receptors, Dopamine D2; Reproducibility of Results; Riluzole; Treatment Outcome	2005
Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism & related disorders, 2005, Volume: 11, Issue:6 Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Catechols; Databases, Factual; Dopamine Agonists; Humans; Indoles; Levodopa; Male; Mental Disorders; Middle Aged; Multiple System Atrophy; Nitriles; Parkinson Disease; Pramipexole; Sexual Dysfunctions, Psychological; Thiazoles	2005
Augmentation of artistic productivity in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:2 Topics: Antiparkinson Agents; Art; Carbidopa; Creativity; Dopamine Agents; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Frontal Lobe; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Poetry as Topic	2006
Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements. Neurology, 2006, May-23, Volume: 66, Issue:10 Topics: Animals; Antiparkinson Agents; Cocaine; Dihydroxyphenylalanine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Duodenum; Humans; Indoles; Infusion Pumps; Levodopa; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome	2006
Decreased expression of l-dopa-induced dyskinesia by switching to ropinirole in MPTP-treated common marmosets. Experimental neurology, 2007, Volume: 204, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Callithrix; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Indoles; Levodopa; Male; Motor Activity	2007
[Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy]. Fortschritte der Neurologie-Psychiatrie, 2007, Volume: 75, Issue:4 Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Depression; Disability Evaluation; Dopamine Agonists; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease	2007
The administration of entacapone prevents L-dopa-induced dyskinesia when added to dopamine agonist therapy in MPTP-treated primates. Experimental neurology, 2007, Volume: 208, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Callithrix; Catechols; Dopamine Agents; Dopamine Agonists; Drug Administration Schedule; Drug Synergism; Dyskinesia, Drug-Induced; Female; Indoles; Levodopa; Male; Motor Activity; Nitriles	2007
Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight. European journal of neurology, 2008, Volume: 15, Issue:5 Topics: Age Factors; Aged; Antiparkinson Agents; Body Size; Body Weight; Dyskinesia, Drug-Induced; Female; Humans; Indoles; Levodopa; Logistic Models; Male; Middle Aged; Odds Ratio; Parkinson Disease	2008
Appropriate use of dopamine agonists and levodopa in restless legs syndrome in an ambulatory care setting. The Annals of pharmacotherapy, 2008, Volume: 42, Issue:5 Topics: Adult; Ambulatory Care; Dopamine Agonists; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Restless Legs Syndrome; Retrospective Studies	2008
Heart valve abnormalities in Parkinson's disease treated with dopamine agonists. Journal of neurology, 2008, Volume: 255, Issue:10 Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Echocardiography; Female; Heart Valve Diseases; Heart Valves; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole	2008
Unilateral RLS with predominantly ipsilateral PLMS and variable response to dopaminergic drugs: a variant of idiopathic RLS? European journal of neurology, 2009, Volume: 16, Issue:3 Topics: Aged; Dopamine Agents; Electromyography; Functional Laterality; Humans; Indoles; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Nocturnal Myoclonus Syndrome; Polysomnography; Restless Legs Syndrome; Spinal Cord; Treatment Outcome; Young Adult	2009
Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease. Mayo Clinic proceedings, 2009, Volume: 84, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Carbidopa; Compulsive Behavior; Dopamine Agonists; Female; Gambling; Humans; Indoles; Levodopa; Libido; Male; Middle Aged; Parkinson Disease; Pramipexole; Retrospective Studies	2009
[Socioeconomic relevance of the idiopathic restless legs syndrome (RLS) in Germany: cost-of-illness study]. Medizinische Klinik (Munich, Germany : 1983), 2009, May-15, Volume: 104, Issue:5 Topics: Benzothiazoles; Delayed-Action Preparations; Dopamine Agents; Dopamine Agonists; Drug Costs; Financing, Personal; Germany; Health Care Costs; Humans; Indoles; Levodopa; Long-Term Care; Markov Chains; Models, Economic; National Health Programs; Practice Guidelines as Topic; Pramipexole; Resource Allocation; Restless Legs Syndrome; Socioeconomic Factors; Treatment Outcome	2009
Agonist or levodopa for Parkinson disease? Ultimately, it doesn't matter; neither is good enough. Neurology, 2009, Jun-16, Volume: 72, Issue:24 Topics: Bromocriptine; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Follow-Up Studies; Humans; Indoles; Levodopa; Parkinson Disease; Practice Patterns, Physicians'; Prevalence; Randomized Controlled Trials as Topic; Time; Treatment Outcome	2009
Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment. Journal of the neurological sciences, 2009, Dec-15, Volume: 287, Issue:1-2 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Comorbidity; Disability Evaluation; Dopamine Agonists; Female; Gastrointestinal Diseases; Humans; Indoles; Levodopa; Male; Memory Disorders; Middle Aged; Mood Disorders; Movement Disorders; Neurologic Examination; Nocturia; Outcome Assessment, Health Care; Parkinson Disease; Pramipexole; Prevalence; Restless Legs Syndrome; Treatment Outcome	2009
Sustained dopaminergic response of parkinsonism and depression in POLG-associated parkinsonism. Movement disorders : official journal of the Movement Disorder Society, 2010, Jan-30, Volume: 25, Issue:2 Topics: Affect; Depression; DNA Polymerase gamma; DNA-Directed DNA Polymerase; Dopamine Agents; Female; Humans; Indoles; Levodopa; Middle Aged; Parkinsonian Disorders; Radionuclide Imaging; Treatment Outcome	2010
Pre-treatment with dopamine agonists influence L-dopa mediated rotations without affecting abnormal involuntary movements in the 6-OHDA lesioned rat. Behavioural brain research, 2010, Nov-12, Volume: 213, Issue:1 Topics: Animals; Antiparkinson Agents; Bromocriptine; Corpus Striatum; Dopamine Agonists; Dyskinesia, Drug-Induced; Enkephalins; Female; Indoles; Levodopa; Oxidopamine; Parkinsonian Disorders; Piribedil; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rotation; Time Factors	2010
Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Archives of neurology, 2010, Volume: 67, Issue:5 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Binge-Eating Disorder; Comorbidity; Cross-Sectional Studies; Disruptive, Impulse Control, and Conduct Disorders; Female; Gambling; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Prevalence; Risk Factors; Sexual Dysfunctions, Psychological	2010
Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) with fatal outcome, after the manifestation of an ampullary adenocarcinoma. Pancreas, 2010, Volume: 39, Issue:5 Topics: Adenocarcinoma; Aged; Amantadine; Ampulla of Vater; Antiparkinson Agents; Common Bile Duct Neoplasms; Fatal Outcome; Female; Humans; Indoles; Levodopa; Supranuclear Palsy, Progressive	2010
Isolated delusional syndrome in Parkinson's Disease. Parkinsonism & related disorders, 2010, Volume: 16, Issue:8 Topics: Aged; Amantadine; Antiparkinson Agents; Benserazide; Benzothiazoles; Catechols; Clonazepam; Female; Humans; Indans; Indoles; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Pramipexole; Schizophrenia, Paranoid; Syndrome	2010
Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample. Sleep medicine, 2011, Volume: 12, Issue:5 Topics: Adult; Aged; Benzothiazoles; Cross-Sectional Studies; Dopamine Agonists; Female; Health Surveys; Humans; Indoles; Levodopa; Male; Middle Aged; Outpatients; Patient Satisfaction; Pergolide; Pramipexole; Restless Legs Syndrome; Risk Factors; Treatment Failure	2011
Myometry revealed medication-induced decrease in resting skeletal muscle stiffness in Parkinson's disease patients. Clinical biomechanics (Bristol, Avon), 2012, Volume: 27, Issue:6 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Body Mass Index; Electromyography; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Muscle Contraction; Muscle Rigidity; Muscle, Skeletal; Parkinson Disease; Piribedil; Stress, Mechanical	2012
Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease. Neurobiology of disease, 2012, Volume: 47, Issue:3 Topics: 5,6-Dihydroxytryptamine; Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Antiparkinson Agents; Buspirone; Cell Count; Creatinine; Disease Models, Animal; Dopamine Agonists; Dopaminergic Neurons; Dyskinesia, Drug-Induced; Female; Indoles; Levodopa; Motor Activity; Oxidopamine; Parkinson Disease; Pyridines; Rats; Rats, Sprague-Dawley; Serotonergic Neurons; Serotonin Receptor Agonists; Time Factors	2012
'You never told me I would turn into a gambler': a first person account of dopamine agonist--induced gambling addiction in a patient with restless legs syndrome. BMJ case reports, 2011, Aug-24, Volume: 2011 Topics: Cabergoline; Carbidopa; Cognitive Behavioral Therapy; Dopamine Agonists; Drug Combinations; Ergolines; Gambling; Humans; Indoles; Levodopa; Male; Middle Aged; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes	2011
Duration of L-dopa and dopamine agonist monotherapy in Parkinson's disease. Scottish medical journal, 2012, Volume: 57, Issue:4 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Confidence Intervals; Disorders of Excessive Somnolence; Disruptive, Impulse Control, and Conduct Disorders; Dizziness; Dopamine Agonists; Drug Therapy, Combination; Female; Hallucinations; Humans; Indoles; Kaplan-Meier Estimate; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Time Factors	2012
Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series. European journal of neurology, 2013, Volume: 20, Issue:9 Topics: Dopamine Agonists; Female; Humans; Indoles; Levodopa; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes	2013
Effects of dopaminergic and subthalamic stimulation on musical performance. Journal of neural transmission (Vienna, Austria : 1996), 2013, Volume: 120, Issue:5 Topics: Adult; Auditory Perceptual Disorders; Deep Brain Stimulation; Dopamine Agents; Humans; Indoles; Levodopa; Male; Movement; Music; Parkinson Disease; Psychomotor Performance; Subthalamic Nucleus; Time Perception	2013
Three cases of impulse control disorder in Parkinson's disease patients receiving dopamine replacement therapy. Irish medical journal, 2013, Volume: 106, Issue:1 Topics: Adult; Amantadine; Antiparkinson Agents; Benzothiazoles; Carbidopa; Catechols; Disruptive, Impulse Control, and Conduct Disorders; Drug Combinations; Female; Humans; Indans; Indoles; Levodopa; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Pramipexole; Selegiline	2013
The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation. Neurobiology of disease, 2014, Volume: 62 Topics: Amphetamine; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Benzazepines; Buspirone; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopaminergic Neurons; Dyskinesia, Drug-Induced; Female; Indoles; Levodopa; Mesencephalon; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Serotonin Receptor Agonists	2014
Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study. Journal of neurology, neurosurgery, and psychiatry, 2014, Volume: 85, Issue:8 Topics: Administration, Cutaneous; Administration, Oral; Age Factors; Aged; Antiparkinson Agents; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Sex Factors; Tetrahydronaphthalenes; Thiophenes	2014
Teaching NeuroImages: Pisa syndrome in Parkinson disease. Neurology, 2014, Nov-04, Volume: 83, Issue:19 Topics: Aged; Carbidopa; Drug Combinations; Dystonia; Humans; Indoles; Levodopa; Male; Parkinson Disease; Posture; Scoliosis	2014
Serotonin syndrome in stroke patients. Journal of rehabilitation medicine, 2015, Volume: 47, Issue:3 Topics: Carbidopa; Dopamine Agonists; Drug Combinations; Humans; Indoles; Levodopa; Male; Middle Aged; Serotonin Syndrome; Stroke	2015
The adenosine A2A receptor antagonist, istradefylline enhances the anti-parkinsonian activity of low doses of dopamine agonists in MPTP-treated common marmosets. European journal of pharmacology, 2015, Jan-15, Volume: 747 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Callithrix; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Synergism; Female; Indoles; Levodopa; Male; Motor Activity; Pergolide; Purines; Receptor, Adenosine A2A	2015
Head-to-Head Comparison of the Neuropsychiatric Effect of Dopamine Agonists in Parkinson's Disease: A Prospective, Cross-Sectional Study in Non-demented Patients. Drugs & aging, 2015, Volume: 32, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Apathy; Benzothiazoles; Cross-Sectional Studies; Dopamine Agonists; Educational Status; Female; Humans; Indoles; Levodopa; Male; Mental Disorders; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pramipexole; Prospective Studies; Psychotropic Drugs; Spain	2015
The adenosine A2A receptor antagonist, istradefylline enhances anti-parkinsonian activity induced by combined treatment with low doses of L-DOPA and dopamine agonists in MPTP-treated common marmosets. European journal of pharmacology, 2015, Nov-05, Volume: 766 Topics: Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Behavior, Animal; Callithrix; Dopamine Agonists; Drug Therapy, Combination; Female; Indoles; Levodopa; Male; Motor Activity; MPTP Poisoning; Pergolide; Purines	2015
Parkinson's disease: initial treatment of motor disorders. Prescrire international, 2015, Volume: 24, Issue:163 Topics: Age Factors; Antiparkinson Agents; Drug Administration Schedule; Humans; Indoles; Levodopa; Motor Activity; Parkinson Disease; Physical Therapy Modalities; Time-to-Treatment; Treatment Outcome	2015
Dementia with Lewy bodies presenting marked tongue protrusion and bite due to lingual dystonia: A case report. Rinsho shinkeigaku = Clinical neurology, 2016, 06-22, Volume: 56, Issue:6 Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Bites and Stings; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Indoles; Laryngeal Diseases; Levodopa; Lewy Body Disease; Middle Aged; Olanzapine; Receptors, Dopamine D1; Tetrahydronaphthalenes; Thiophenes; Tongue Diseases	2016
Drug-induced gambling disorder: A not so rare but underreported condition. Psychiatry research, 2018, Volume: 269 Topics: Aged; Aged, 80 and over; Dopamine Agonists; Gambling; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole	2018
Long-term study of ropinirole patch in Parkinson's disease patients with/without basal l-dopa. Parkinsonism & related disorders, 2021, Volume: 83 Topics: Adult; Aged; Dopamine Agonists; Drug Substitution; Female; Humans; Indoles; Levodopa; Longitudinal Studies; Male; Middle Aged; Outcome Assessment, Health Care; Severity of Illness Index; Transdermal Patch	2021
Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson's disease. PloS one, 2021, Volume: 16, Issue:7 Topics: Aged; Antiparkinson Agents; Cross-Sectional Studies; Dopamine Agonists; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Regression Analysis; Retrospective Studies; Sleep; Tetrahydronaphthalenes; Thiophenes	2021
Ropinirole Cotreatment Prevents Perivascular Glial Recruitment in a Rat Model of L-DOPA-Induced Dyskinesia. Cells, 2023, 07-14, Volume: 12, Issue:14 Topics: Animals; Antiparkinson Agents; Dopamine; Dopamine Agonists; Dyskinesia, Drug-Induced; Levodopa; Microglia; Rats	2023